文献速递临床免疫质量管理与危急值

抗磷脂抗体检测方法在APS诊断中的综合评估:不同检测系统与临床亚型的性能比较

Comprehensive evaluation of antiphospholipid antibody testing methodologies in APS diagnosis: performance comparisons across assay systems and clinical subtypes.
PubMed 文献 · Clin Chem Lab Med · 2025-06-27

结果显示IgG亚型一致性最高、IgA最低,CLIA系统分类性能优于ELISA,最高AUC达0.811(灵敏度0.730、特异度0.891),IgG整体表现最佳,纳入IgA可 modestly 提高部分系统灵敏度但可能降低特异度。

要点

  • CLIA系统检测aCL和aβ2GPI的诊断准确性优于ELISA系统。
  • IgG亚型检测一致性及诊断性能最佳,IgA变异性最大。
  • 纳入IgA检测可提高部分系统灵敏度,但可能伴随特异度下降。

核心结论

  • 商业aPL检测系统间存在显著变异,CLIA方法较ELISA具有更好的一致性和诊断准确性。
  • 纳入IgA检测对IgG/IgM型aCL和aβ2GPI阴性的APS患者有额外诊断价值。

研究设计与样本

  • 使用六种商业平台(三种ELISA和三种CLIA)检测aCL和aβ2GPI的IgA、IgG、IgM亚型。
  • 比较各平台间检测一致性,并用ROC曲线分析评估诊断性能。

主要发现

  • IgG亚型在各平台间一致性最高,IgA一致性最低。
  • CLIA系统整体分类性能优于ELISA,最高AUC达0.811,灵敏度和特异度分别达0.730和0.891。
  • IgG亚型整体表现最佳,IgA和IgM变异性较大。
  • 纳入IgA可 modestly 提高部分系统灵敏度,但有时伴随特异度下降。
  • LA阳性患者aPL阳性率高于LA阴性患者,血栓性APS患者aPL水平高于产科APS患者。

关键数值与推荐

  • 最高AUC为0.811,对应灵敏度0.730、特异度0.891。

临床怎么用

  • 临床选择aPL检测系统时应考虑CLIA方法可能提供更好的一致性和诊断准确性。
  • 对IgG/IgM型aCL和aβ2GPI阴性的疑似APS患者,可考虑加测IgA以辅助诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by thrombosis and obstetric complications associated with antiphospholipid antibodies (aPLs). This study aimed to compare the diagnostic performance of six commercial assay systems for detecting aCL and aβ2GPI antibodies. METHODS: Sixty-three APS patients, 50 SLE patients, 67 disease controls, and 62 healthy controls were enrolled. aCL and aβ2GPI antibodies of IgA, IgG, and IgM isotypes were measured using six commercial platforms, including three ELISA-based systems and three CLIA-based systems. Inter-assay concordance was compared across all detection platforms, and ROC curve analysis was performed to evaluate and compare their diagnostic performance in APS. RESULTS: Inter-assay concordance varied across platforms, with IgG isotypes showing the highest consistency and IgA exhibiting the lowest agreement. Overall, CLIA-based systems demonstrated superior classification performance compared to ELISA-based methods. The highest area under the curve (AUC) reached 0.811, with sensitivity and specificity up to 0.730 and 0.891, respectively. IgG isotypes demonstrated the best overall performance, while IgA and IgM showed greater variability. The inclusion of IgA modestly improved sensitivity in some systems, although this was sometimes accompanied by decreased specificity. LA-positive patients had higher aPL positivity rates than LA-negative ones, and aPL levels were higher in thrombotic vs. obstetric APS. CONCLUSIONS: Significant variability exists among commercial aPL detection systems. CLIA-based methods provided better consistency and diagnostic accuracy than ELISA. The inclusion of IgA provided additional diagnostic value in identifying APS patients who tested negative for aCL and aβ2GPI of the IgG and IgM isotypes.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Wang Y, Yuan X, Wang T, et al. Comprehensive evaluation of antiphospholipid antibody testing methodologies in APS diagnosis: performance comparisons across assay systems and clinical subtypes. Clin Chem Lab Med. 2025. PMID: 40569180. doi:10.1515/cclm-2025-0499

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。